Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Gold loans are no longer merely the last source of credit for the poor: Shaji Varghese, CEO, Muthoot FinCorp
Muthoot Fincorp is gearing up for a monumental ₹4,000 crore IPO, seeking to ignite its expansion plans and harness the momentum of its current growth trajectory. With an optimistic eye on the future, the company is poised to navigate market fluctuations and continue its upward path. The funds raised will be pivotal in propelling further innovations and initiatives.
India missed out on AI, and now its run as market darling may be over
India's stock market faces a significant downturn as global investment shifts towards AI. Foreign investors are leaving, impacting market value. The country's IT sector, a major driver of past success, is now vulnerable to AI automation. This presents a critical juncture for India's economic future and its position in global markets.
Iran war effect: Leading EV two-wheeler makers accelerate expansion amid petrol price worries
Major electric scooter companies are rapidly increasing production capacity. This expansion aims to meet a surge in demand for eco-friendly vehicles. Combined monthly output is expected to nearly double by the end of the fiscal year. This signals a shift towards mass-market adoption. Companies are navigating challenges while betting on strong future growth.
Open to 4-5 acquisitions, but at sensible valuations: Ameera Shah, promoter and executive chairperson, Metropolis Healthcare
Metropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic acquisitions will also play a key role. The company aims to expand services beyond pathology. This strategy will drive future growth and strengthen its market position.
Alembic Pharma gets USFDA tentative nod for generic prostate cancer drug
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate cancer treatment. The approval is for the 300 mg strength. The drug is a generic version of Nubeqa Tablets. The robust market potential for these tablets suggests promising future growth for Alembic.
Will start introducing India-specific models from 2028, to leverage on 2W biz: Honda Global CEO
Honda plans to launch new car models specifically for India starting in 2028. The company will use its strong motorcycle sales to encourage customers to upgrade to cars. India is a key market for Honda's future growth. Production capacity for two-wheelers will also increase. Honda aims to strengthen its automotive business in India through these strategic moves.
India's EV battery demand to grow 10 times to 200 GWh by 2032: IESA
India's electric vehicle battery demand will surge tenfold by 2032. This growth presents significant opportunities in component localization and supply chain development. The market is transforming with advancements in batteries, motors, and manufacturing. Electric two-wheelers lead sales, but passenger cars and light commercial fleets will drive future expansion. New battery chemistries and motor technologies are emerging.
ET Alpha Wealth Summit: Market titans decode AI, wealth creation & India’s next investment cycle
As markets grow volatile, the Economic Times' Alpha Wealth Summit in Mumbai will gather experts to discuss future wealth creation. Sessions will cover finding alpha, building a Rs 100 crore portfolio in a lower-return environment, and navigating India's next decade amidst AI's rise.
From oncology to obesity, Pfizer bets big on India for its next growth wave
Pfizer is focusing on India for future growth. The company plans to launch new medicines quickly and at affordable prices. India is seen as a crucial market for new treatments in cancer, obesity, and vaccines. Pfizer is also working on local clinical studies for future drug launches.
US CPI records biggest jump in 3 years: Can the Fed raise interest rates after hot inflation data?
The US consumer price index has jumped to a three-year high of 3.8%, prompting questions about potential interest rate hikes by the Federal Reserve. Economists weigh in on the impacts of rising oil prices and economic stability, leaving the market in suspense about future monetary policy.
US Stock Market: Why investors are betting big on Kopin’s AI future - The Economic Times
US Stock Market: Why investors are betting big on Kopin’s AI futureThe Economic Times
Can Reliance Jio's fresh-issue play restore faith in India's billion-dollar IPOs?
Reliance Jio may change its IPO plan. Instead of existing investors selling shares, it could be a fresh issue. This means money goes directly into Jio Platforms for debt reduction and expansion. This move could restore investor faith in large Indian IPOs. It might set a new standard for future mega listings. The market will watch this development closely.